Low-dose vaginal estrogens, available in various applications such as creams, tablets, inserts, and rings, are the mainstay of GSM treatment.

Prostate cancer is the second-leading cause of death in American men. However, prostate cancer is curable, thanks to options ...

Dr Daniel Petrylak discusses groundbreaking advancements in prostate cancer treatment, including genetic mutations, PARP ...

Writer Eileen Kelly had a burning question (and sensation)—and after a long and winding journey, doctors finally answered it.

Cancer surgery patients whose health team tracked their symptoms remotely during recovery wound up recovering more quickly ...

This extract here, from Chapter 10, Love Your Vulva, begins with the story of a 73-year-old woman who suffered in silence ...

In the discussion, Petrylak highlighted advances in identifying genetic mutations and emerging strategies for early, intensive treatment for prostate cancer.

The loss of productivity and health expenses associated with menopause cost the U.S. economy $26 billion annually. Workdays missed due to menopause symptoms added up to another $1.8-billion annual ...

A 2022 German study found nearly half of GPs address sexual issues less often than clinical situations would suggest.

Multiple sclerosis (MS) patients treated with ocrelizumab (Ocrevus) had a higher risk of infections over time than other MS ...

MiraDx, a molecular diagnostics company advancing germline-based personalization of cancer treatment, announced today a study from UCLA that will be presented at the 2025 American Society for ...

The rate of death from second primary malignancies has increased among older prostate cancer survivors in the US, data suggest.